Igm Biosciences, Inc. Files SEC Form DEFA14A, Additional Definitive Proxy Soliciting Materials And Rule 14(A)(12) Material: (Apr. 26, 2024).
In: Pharma Business Week, 2024-05-13, S. 1641
Zeitungsartikel
Zugriff:
Titel: |
Igm Biosciences, Inc. Files SEC Form DEFA14A, Additional Definitive Proxy Soliciting Materials And Rule 14(A)(12) Material: (Apr. 26, 2024).
|
---|---|
Zeitschrift: | Pharma Business Week, 2024-05-13, S. 1641 |
Veröffentlichung: | 2024 |
Medientyp: | Zeitungsartikel |
ISSN: | 1543-6675 (print) |
Sonstiges: |
|